Grove Biopharma

Chicago, IL · Founded 2020 · Privately Held (backing)

Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. Grove Biopharma is based in Chicago, IL and was founded in 2020. Its last reported valuation was $64 million in Apr 2025. It has raised $44 million.

Last reported valuation

$64.0M

Oct 2026

Priced at

—

Total raised

$44.0M

Last round

—

How much has Grove Biopharma raised?

$44.0Macross 0 recorded rounds

Free account

More of Grove Biopharma with a free account

·The complete investor list: 13 names
·Watch Grove Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Grove Biopharma investors

13 investors are on record for Grove Biopharma, including DCVC Bio, Skydeck Capital, Mansueto Office and Deepwork Capital.

For fundraisers

Raising for a company like Grove Biopharma?

13 investors have backed Grove Biopharma.

See all 13 investors →

Frequently asked about Grove Biopharma

How much has Grove Biopharma raised?: Grove Biopharma has raised $44.0M in total across 0 recorded funding rounds.